Trials / Completed
CompletedNCT00297505
Serotonin, Impulsivity, and Cocaine Dependence Treatment
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effects of citalopram versus placebo given in the context of contingency management for cocaine dependence.
Detailed description
Cocaine dependence continues to be a significant public health problem, for which there is no FDA approved pharmacotherapy. This study is a 12-week, double blind, placebo controlled trial of citalopram for cocaine dependence. The primary outcome measure is benzoylecgonine positive urines. Secondary measures of side effects and craving are also examined.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | citalopram |
Timeline
- Start date
- 2001-04-01
- Completion
- 2004-11-01
- First posted
- 2006-02-28
- Last updated
- 2017-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00297505. Inclusion in this directory is not an endorsement.